| Q70146780 | A phase II trial of gallium nitrate (NSC #15200) in advanced or recurrent squamous cell carcinoma of the cervix. A Gynecologic Oncology Group study |
| Q70340567 | Bone modeling in gallium nitrate-treated rats |
| Q39380445 | Clinical pharmacology and clinical trials of ribonucleotide reductase inhibitors: is it a viable cancer therapy? |
| Q40648722 | Complexes of metals other than platinum as antitumour agents |
| Q52234207 | Developmental toxicity evaluation of gallium nitrate in mice. |
| Q40385542 | Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use. |
| Q36390099 | Effect of gallium nitrate on the expression of osteoprotegerin and receptor activator of nuclear factor‑κB ligand in osteoblasts in vivo and in vitro |
| Q40104510 | Effect of human renal and hepatic disease on the pharmacokinetics of anticancer drugs |
| Q38868528 | Gallium Compounds Exhibit Potential as New Therapeutic Agents against Mycobacterium abscessus. |
| Q28344777 | Gallium disrupts iron metabolism of mycobacteria residing within human macrophages |
| Q34671623 | Gallium in cancer treatment. |
| Q30435172 | Gallium nitrate |
| Q66956856 | Gallium nitrate (NSC-15200) induced toxicity in the rat.A pharmacologic, histopathologic and microanalytical investigation |
| Q35779262 | Gallium nitrate for the treatment of non-Hodgkin's lymphoma |
| Q34610428 | Gallium nitrate inhibits calcium resorption from bone and is effective treatment for cancer-related hypercalcemia |
| Q36685466 | Gallium nitrate. A review of its pharmacological properties and therapeutic potential in cancer related hypercalcaemia |
| Q36616612 | Gallium-containing anticancer compounds |
| Q51718447 | In vivo and in vitro modulation of carp (Cyprinus carpio L.) phagocyte oxidative burst activity by gallium. |
| Q42154815 | Inhibition of liver, kidney, and erythrocyte delta-aminolevulinic acid dehydratase (porphobilinogen synthase) by gallium in the rat. |
| Q33965885 | Medical applications and toxicities of gallium compounds |
| Q28389111 | Metabolism and possible health effects of aluminum |
| Q33941488 | NMR determination of free gallium(III) ions in aqueous solutions of Ga complexes, "cold" analogs of PET/SPECT tracers. |
| Q36115090 | P-glycoprotein expression in Ehrlich ascites tumour cells after in vitro and in vivo selection with daunorubicin |
| Q34215957 | Pharmacokinetics of gallium nitrate after oral administration in adult horses--pilot study |
| Q33437498 | Phase II evaluation of gallium nitrate by continuous infusion in breast cancer |
| Q71048563 | Phase II trial of gallium nitrate, amonafide and teniposide in metastatic non-small cell lung cancer. An Eastern Cooperative Oncology Group study (E2588) |
| Q35153311 | Prolonged-acting, multi-targeting gallium nanoparticles potently inhibit growth of both HIV and mycobacteria in co-infected human macrophages. |
| Q57266672 | Relative efficacy of chelating agents as antidotes for acute gallium nitrate intoxication |
| Q38188468 | Repurposing of gallium-based drugs for antibacterial therapy. |